Profility

United States - Boston, Massachusetts

• 10/04/2023
• Series B
• Undisclosed Amount

Profility provides technology that enables truly personalized care planning, by optimizing decisions and transitions within a healthcare ecosystem and leveraging existing knowledge about how patients will respond to a particular treatment or pathway. This ability to understand the patient and his or her UNIQUE CHARACTERISTICS is what sets our solution apart.
Our advanced profiling technology matches patients to clusters of near-clones and then draws on existing data regarding how such patients reacted to treatment/care pathways. Profility looks beyond the average patient to personalize care.
Profility combines advanced profiling based on big data with proprietary algorithms to discover hidden patterns and previously hard-to-identify groups of similar patients. Big data holds significant promise, but it only works if you can turn data into knowledge, and put that knowledge to work, and that is where Profility comes in. Predictive analytics provides vast potential to improve the way we dig into existing information and apply new knowledge to deliver better healthcare.
Profility uses advanced profiling to construct homogenous clusters of patients from the bottom up, starting with a specific patient’s individual profile. Patients within each cluster share characteristics, and can thus be used to understand the effectiveness of different treatments and different providers.

Related People

Erez SchachterFounder

United States - Brookline, Massachusetts

N/A

LinkedIn https://www.linkedin.com/in/erez-schachter-57630a/